Thursday, December 9, 2021

TOPIC

Vaccine trial

Bharat Biotech releases Phase-3 trials data of Covaxin: Indian-made vaccine 77.8% effective against mild cases, 93% against severe cases

Bharat Biotech announced efficacy analysis data from Phase-3 clinical trials of Covaxin, proved to be highly effective against severe cases of COVID-19

Zydus Cadila applies for emergency use approval for its ZyCov-D vaccine, ready to produce 5 crore doses by 2021 end

Sharvil Patel, MD, Cadila Healthcare said, "As the first-ever plasmid DNA vaccine for human use, ZyCoV-D has proven its safety and efficacy profile in our fight against Covid-19".

Cases of Wuhan virus surge in Bahrain, UAE despite Chinese vaccine, countries opt for Pfizer booster doses

In a separate trial in Serbia, 29% of 150 participants were found to have zero antibodies against the virus even after three months. In addition, the average age of the people who participated in the Serbian study was higher than 65.

Arvind Kejriwal bats for Pfizer even as the company wants protection from being sued if vaccines give adverse effects

So far, the government has not given such protection from liability to any of the three vaccines currently approved for use in India - Covishield, Covaxin, or Sputnik V.

The false claims of COVID-19 vaccine shortage and the propaganda for American vaccines: A detailed analysis

While non-NDA states are lagging behind vaccinating eligible population, they are demanding to open up the vaccines to all adults

Bharat Biotech’s Covaxin shows 81% efficacy, phase 3 trials with 25,800 subjects completed

The phase 3 trials involved 25,800 subjects. The trial, done in collaboration with ICMR, is the largest ever clinical trial done in India.

China upset over Modi govt’s vaccine diplomacy, blames India after Bangladesh rejects their vaccine

Chinese government mouthpiece Global Times has claimed that India wants to monopolize the vaccine market in South Asia and hence is influencing its neighbouring nations to reject the Chinese vaccine.

‘Cause of death is poisoning, not vaccine’: Bharat Biotech issues clarification after phase 3 trial participant for Covaxin dies in Bhopal

The volunteer from Bhopal in Madhya Pradesh had died 10 days after he had participated in the clinical trial for Covaxin

After refusing to take ‘BJP vaccine’ for coronavirus, Akhilesh Yadav does a u-turn

Yesterday, Akhilesh Yadav tried to create panic in the society by stating that he would get vaccinated only when his government will be formed after the next election.

Congratulations India: PM Modi expresses gratitude as DCGI approves Made in India Bharat Biotech vaccine for Coronavirus

PM Modi had also expressed his gratitude for health workers, doctors, sanitation workers and other frontline warriors, who had put their lives in risk in the most adverse of circumstances.

Latest News

Recently Popular

Connect with us

255,564FansLike
586,485FollowersFollow
25,400SubscribersSubscribe